Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Cash from Investing Activities (2022 - 2025)

Prokidney (PROK) has disclosed Cash from Investing Activities for 4 consecutive years, with $29.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities rose 135.55% to $29.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $91.0 million, a 200.49% increase, with the full-year FY2024 number at $20.4 million, up 106.19% from a year prior.
  • Cash from Investing Activities was $29.0 million for Q3 2025 at Prokidney, up from $18.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $58.4 million in Q1 2024 to a low of -$192.6 million in Q1 2023.
  • A 4-year average of -$15.7 million and a median of -$306000.0 in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 31221.57% in 2023, then skyrocketed 317.21% in 2024.
  • Prokidney's Cash from Investing Activities stood at -$306000.0 in 2022, then crashed by 31221.57% to -$95.8 million in 2023, then soared by 115.73% to $15.1 million in 2024, then soared by 92.43% to $29.0 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Cash from Investing Activities are $29.0 million (Q3 2025), $18.6 million (Q2 2025), and $28.3 million (Q1 2025).